(Q40525169)

21 September 2017

1 reference

title

PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency (English)

1 reference

21 September 2017

0 references

M S Hershfield

1

1 reference

21 September 2017

1 January 1995

1 reference

21 September 2017

1 reference

21 September 2017

5

1 reference

21 September 2017

107-112

1 reference

21 September 2017

2

1 reference

IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency

21 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

European experience of bone-marrow transplantation for severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.1380050202

7 January 2021

Identifiers

DOI

10.1002/HUMU.1380050202

1 reference

21 September 2017

1 reference

PubMed ID

7749407